Biocon

GE Capital to invest Rs125 crore in Biocon’s subsidiary Syngene International

31 Oct 2012

Biocon posts good Q2 result; shares up

31 Oct 2012

Biocon among top 20 employers in sector: survey

25 Sep 2012

Biocon plans merger with biopharma subsidiary

18 Jul 2012

Abbott collaborates with Syngene to open first nutrition research centre in India

05 May 2012

Pfizer terminates $350-mn insulin marketing deal with Biocon

13 Mar 2012

In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US

Biocon arm Clinigene in pact with US company for speciality biomarkers

21 Dec 2011

Biocon posts Rs86 crore net profit for quarter ended September

22 Oct 2011

Biocon to set biopharmaceutical plant, R&D centre in Malaysia

12 Sep 2011

Biocon clinical arm, Spaulding of US in clinical trial partnership

22 Aug 2011

New cancer facility opens at Mazumdar-Shaw Cancer Center, Bangalore

07 May 2011

Biocon to divest stake in Germany's AxiCorp

28 Apr 2011

Biocon Ltd had acquired a controlling stake in the German drug distributor in a bid to market its bio-similar drugs in Europe

Biocon to invest $161 million in Malaysian biotech firm

28 Oct 2010

Biocon second-quarter bottomline up 20 per cent Y-O-Y

22 Oct 2010

Pfizer, Biocon enter into deal for biosimilar insulin

19 Oct 2010

Havana's CIM S A to collaborate in immunology research with Biocon

27 Sep 2010

Biocon net profit up 33 per cent

24 Jul 2010

Biocon arm to buy out CIMAB's 49 per cent stake in Biocon Biopharma

05 Apr 2010

Biocon arm Syngene, Endo Pharma tie up for biological cancer drug

22 Mar 2010

India should focus on affordable innovation: Kiran Mazumdar-Shaw

08 Mar 2010

Biotech sector set to grow by leaps and bounds, says Biocon chief

20 Jan 2010

Biocon, HCG hospitals team up to fight cervical cancer

10 Dec 2009

Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon

01 Oct 2009

Biocon in hybrid drug development pact with Amylin

11 Sep 2009

Biocon Q1 net profit rises four-fold to Rs57 crore

23 Jul 2009